Chronic renal failure
Conditions
Interventions
Health Consultation(Medication Teaching, Exercising Guidance, Nutrition Guidance) - Intervention period: One month (baseline) - Intervention frequency: Four times a month (a standard) - Term for ev
Sponsors
Osaka University
Tohoku University, Juntendo University, Kyoto University, Hyogo College Of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: This study includes patients less than 70 years of age with chronic and end-stage renal failure taking phosphate binders, such as Fosrenol, sevelamer, and calcium carbonate. 1) Patients with chronic and end-stage renal failure 2) Patients at least 20 but less than 70 years of age 3) Patients able to visit the hospital regularly 4) Patients without serious systemic diseases or functional disorders 5) Sex: male or female 6) Patients taking a phosphate binder
Exclusion criteria
Exclusion criteria: The following are criteria for exclusion from this study in terms of the reliability of assessing the study endpoint. 1) Clinical findings A. Mental disorder B. Malignant tumors C. A history of concomitant active infection D. Poorly controlled diabetes 2) Others - Patients with marked restriction of activities of daily living (severity) - Participants in a clinical study/ trial In addition, patients judged to be ineligible by the attending physicians are to be excluded from this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| "Amount of behavior modification" :change in medication dosage (unit: optimal dosage of medication / ideal dosage of medication) | — |
Countries
Japan
Contacts
Public ContactTomoyuki Takura
Osaka University Graduate School of Medicine
Outcome results
None listed